Navigation Links
DNA Medicine Institute Completes Reduced-Gravity Experiments on its NASA-Funded rHEALTH Sensor
Date:12/14/2010

CAMBRIDGE, Mass., Dec. 14, 2010 /PRNewswire/ -- The DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments on its rHEALTH sensor for the 2010 Facilitated Access to the Space Environment for Technology (FAST) program, at the National Aeronautics and Space Administration (NASA) in Houston, Texas, at the end of September.  The rHEALTH sensor is designed to extract a multitude of diagnostic information from a single drop of blood.  Although designed for use in reduced-gravity environments in space, the technology can be applied to real-time health monitoring at patient's bedside or in a doctor's office, and allow for real-time clinical intervention in acute situations.  It was one of 17 technology demonstration projects, from 10 different states, for reduced-gravity aircraft flights.  The DMI device was subject to zero, lunar, and 1.8 g conditions for periods up to 25 seconds in a Boeing 727 airplane flying repeated parabolic trajectories.  A joint team from DMI and NASA's Glenn Research Center (GRC) successfully performed experiments on the rHEALTH platform, which included sample loading, mixing, and detection.  The device operated without fail on all four lunar and zero gravity flights.

"The reduced gravity tests from NASA's FAST 2010 program provided simulated conditions for implementation of the rHEALTH technology in space.  The ability to successfully operate this technology on the parabolic flights also mean that the device is rugged and robust in environments with vibration and variable g-forces, which may be seen in many emergent clinical scenarios here on Earth," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.

NASA's FAST program is designed to demonstrate whether emerging technologies can perform as expected in the reduced-gravity environment of the moon and Mars, or the Earth orbit's zero-gravity environment, thus allowing the incorporation of new technologies into the agency's flight programs and other commercial aerospace applications.  It can also reduce the risk of using new technologies during space missions by providing an opportunity to prove how they work in a reduced-gravity environment, providing insight, before expensive testing, into the reasons some technologies may fail.

For a complete list of NASA's 17 selected FAST projects, their associated leading organizations, partners and information about previous FAST flights, visit:

http://www.nasa.gov/offices/ipp/innovation_incubator/FAST/index.html

For more on the rHEALTH test, visit:

http://www.dnamedinstitute.com/parabolicflight

About The DNA Medicine Institute

DMI utilizes an interdisciplinary, multi-faceted approach to innovation that draws upon diverse and disparate fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  Its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care. It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  For more information, visit:  www.dnamedinstitute.com.


'/>"/>
SOURCE DNA Medicine Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study
2. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
3. Reportlinker Adds Global Nuclear Medicine Industry
4. China Medicine Reports Third Quarter 2010 Financial Results
5. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
6. Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines
7. Toriseva Law and Karon & Dalimonte LLP: Archives of Internal Medicine Article Faults Manufacturers of IVC Filters
8. Timothy T. Goodnow, Ph.D., Joins Sensors for Medicine and Science, Inc. Board of Directors
9. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
10. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
11. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch to ... - living - adjustment (COLA) is a bad deal for older and disabled Americans, ... index (CPI) would grow even more slowly than the conventional one that is currently ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health care ... unit of Constellation Inc., a move that will help the company better serve its ... Louis, the acquisition is expected to help MTS expand its presence in ...
(Date:7/20/2017)... ... ... “Fidget”: a fun-filled, action-packed memoir of adventures. “Fidget” is the creation of ... who was a summa cum laude graduate of Gardner Webb University. She has won ... her retirement from public school, Lynn continued to pursue her love for music through ...
(Date:7/18/2017)... ... 2017 , ... The results of an international clinical trial, led in part by a UC ... of muscular dystrophy holds promise for a subgroup of patients. , In a paper just ... at 53 study sites in 18 countries describe the clinical benefit of using the drug ...
(Date:7/18/2017)... ... July 19, 2017 , ... ... it’s Corporate Social Responsibility Initiative in the prestigious CEO World Awards®. The ... organizational performance, new products and services, CEO case studies, corporate social responsibility, and ...
Breaking Medicine News(10 mins):